| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/25/1990 | WO1990000565A1 Interleukin ii analogs |
| 01/25/1990 | WO1990000405A1 Immunoconjugates for cancer diagnosis and therapy |
| 01/25/1990 | WO1990000403A1 Genetically engineered coccidiosis vaccine |
| 01/25/1990 | WO1990000402A1 Synthetic vaccine against p. falciparum malaria |
| 01/25/1990 | WO1990000398A1 Method of preparing surface membrane antigens from human carcinoma cells |
| 01/25/1990 | WO1990000396A1 Composition for macrophage activation |
| 01/25/1990 | WO1990000392A1 Purified hematoporphyrin dimers and trimers useful in photodynamic therapy |
| 01/24/1990 | EP0352250A2 Bordetella pertussis vaccine |
| 01/24/1990 | EP0352073A1 Vectors, cells transformed thereby, and their use in producing heterologous polypeptides |
| 01/24/1990 | EP0352060A2 Expression plasmid and use thereof |
| 01/24/1990 | EP0351944A1 Monoclonal antibodies to immunogenic human interleukin-3 peptide |
| 01/24/1990 | EP0351908A1 Live newcastle disease virus vacccines |
| 01/24/1990 | EP0351901A1 Swine kidney cell culture, and its use in vaccine production |
| 01/24/1990 | EP0351876A2 Composition for potentiating vaccination effect |
| 01/24/1990 | EP0351804A2 HCG peptides for use in antibody purification procedures |
| 01/24/1990 | EP0351789A2 Improved monoclonal antibodies reactive with cachectin |
| 01/24/1990 | EP0351731A2 Monoclonal antibodies capable of recognizing gangliosides GQ1b and GT1a |
| 01/24/1990 | EP0351604A1 Neisserial vaccines |
| 01/24/1990 | EP0351426A1 Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process |
| 01/24/1990 | EP0351406A1 Agent preventing the development of disease after hiv infection. |
| 01/23/1990 | US4895932 Method for determining cardiodilatin and fragments thereof and antibodies useful in determination of cardiodilatin and its fragments |
| 01/23/1990 | US4895896 Contact lens having improved eye compatibility |
| 01/23/1990 | US4895804 Bovine antigen glycoprotein, related antibody, and use in detection of pregnancy in cattle |
| 01/23/1990 | US4895800 Biosynthesis, pichia, genetic engineering |
| 01/23/1990 | US4895718 Serotype 2 Marek's disease vaccine |
| 01/23/1990 | US4895717 Revertant serotype 1 Marek's disease vaccine |
| 01/23/1990 | CA1264900A1 POLYPEPTIDE RELATING TO .alpha.-HANP |
| 01/23/1990 | CA1264688A1 Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
| 01/23/1990 | CA1264667A1 Process for the preparation of prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units |
| 01/17/1990 | EP0351322A1 Transformed Shigella |
| 01/17/1990 | EP0351244A2 Antibodies and methods for immunochemical assay using them |
| 01/17/1990 | EP0351045A2 Monoclonal antibody NUH2 capable of inactivating motility of sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen |
| 01/17/1990 | EP0350972A2 Radiolabeled antibody fragments |
| 01/17/1990 | EP0350715A1 Recombinant treponema hyodysenteriae antigen and uses therefor |
| 01/17/1990 | EP0350690A2 Neutralisation of the in vitro and in vivo toxic properties of TNF-alpha by monoclonal antibodies and by fragments derived therefrom |
| 01/17/1990 | EP0350482A1 Immunization |
| 01/17/1990 | CN1038837A Recombinant coccidiosis vaccines |
| 01/16/1990 | US4894443 Polypeptides, antibodies |
| 01/16/1990 | US4894333 Bovine interleukin-1α |
| 01/16/1990 | US4894332 Diagnosis, antibodies |
| 01/16/1990 | US4894229 Carrier-bound immunogenic determinants and carrier therefor |
| 01/16/1990 | US4894228 Vaccine against hepatitis A virus |
| 01/16/1990 | US4894227 Composition of immunotoxins with interleukin-2 |
| 01/16/1990 | US4894225 Combination therapy using antitumor immunotoxins with tumor necrosis factor |
| 01/11/1990 | WO1990000204A1 Novel protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses |
| 01/11/1990 | WO1990000191A1 Production of rabies glycoprotein g and composition therefor |
| 01/11/1990 | WO1990000178A1 Platelet blocking peptides |
| 01/11/1990 | WO1990000063A1 Identification of human t-lymphocyte epitopes in pathogens for vaccine development |
| 01/11/1990 | WO1990000062A1 Antibody recognition of fragments from cytomegalovirus |
| 01/11/1990 | WO1990000061A1 Method for the treatment and the diagnosis of coronary heart disease |
| 01/10/1990 | EP0350398A1 Avirulent antirabies vaccine |
| 01/10/1990 | EP0350230A2 Immunoconjugates for cancer diagnosis and therapy |
| 01/10/1990 | EP0350218A2 Monoclonal antibodies recognizing gamma atrial natriuretic polypeptide, hybridomas producing such antibodies, and their preparation and use |
| 01/10/1990 | EP0349594A1 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
| 01/10/1990 | EP0349583A1 Heliothis expression systems |
| 01/10/1990 | EP0349541A1 Liposomes sensitized to antigenic molecules of intracellular parasites |
| 01/10/1990 | CN1038668A Expression of hepatitis b and pres 2 proteins in methylotrophic yeasts |
| 01/09/1990 | US4892934 Process for preparing hybridoma cells which produce tumor-specific monoclonal antibodies |
| 01/09/1990 | US4892827 Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects |
| 01/09/1990 | US4892824 Fast track method for producing monoclonal bi-specific immunoglobulins |
| 01/09/1990 | CA1264292A1 Purified antigen from non-a, non-b hepatitis causing factor |
| 01/03/1990 | EP0349354A1 Peptides PF10 to PF19 from a retro virus HIV, method for the synthesis of these peptides and their use, particularly in diagnostics |
| 01/03/1990 | EP0349127A1 Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells |
| 01/03/1990 | EP0349071A1 Coccidiosis vaccine |
| 01/03/1990 | EP0348725A2 Species-specific epitode of chlamydia trachomatis and antibodies that recognize the same |
| 01/03/1990 | EP0348442A1 Altered antibody |
| 01/03/1990 | EP0348413A1 Method for the generation of antigen-specific t cell lines and therapeutic use thereof |
| 01/03/1990 | EP0348399A1 Sorbin and peptide derivatives which increase aborption by the mucous membranes. |
| 01/02/1990 | US4891319 Protection of proteins and the like |
| 01/02/1990 | US4891315 Genetic engineering; vaccines |
| 01/02/1990 | US4891226 Pharmaceutical which can be administered nasally, a process for its preparation, and its use |
| 01/02/1990 | US4891219 Method for immunization against and treatment of infection by ectoparasites and endoparasites |
| 01/02/1990 | US4891210 Anticaries |
| 01/02/1990 | US4891208 Steroidal liposomes |
| 01/02/1990 | CA1264148A1 Hydroxylapatite for the analysis and preparation of purified monoclonal antibodies |
| 12/28/1989 | WO1989012693A1 Serotyping dna probes |
| 12/28/1989 | WO1989012690A1 Method for the production of monoclonal antibodies utilizing a germfree animal |
| 12/28/1989 | WO1989012684A1 Fowlpox virus non-essential regions |
| 12/28/1989 | WO1989012683A1 Nucleic acid encoding the p30 protein of toxoplasma gondii |
| 12/28/1989 | WO1989012641A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 12/28/1989 | WO1989012631A1 Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| 12/28/1989 | WO1989012625A1 Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom |
| 12/28/1989 | WO1989012463A1 Method and therapeutic compositions for the treatment of myocardial infarction |
| 12/28/1989 | WO1989012462A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 12/28/1989 | WO1989012460A1 Haemophilus influenzae pilus vaccines |
| 12/28/1989 | WO1989012459A1 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 12/28/1989 | WO1989012458A1 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 12/28/1989 | WO1989012455A1 Stress proteins and uses therefor |
| 12/28/1989 | WO1989012390A1 Biocompatible, substance-specific reagents for treating physiological fluids |
| 12/28/1989 | WO1989010965A3 Glycoprotein h of herpes viruses |
| 12/27/1989 | EP0348261A1 Radiohalogenated compounds for site specific labeling |
| 12/27/1989 | EP0347959A1 Antibodies against fibrin, immunogen used in their preparation, process for determining fibrin and pharmaceutical preparation based on the antibodies |
| 12/27/1989 | EP0347435A1 Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins |
| 12/27/1989 | EP0347433A1 Recombinant antibody |
| 12/27/1989 | EP0175764B1 Method and agents for measuring protein aging |
| 12/27/1989 | CN1038306A Recombinant retroviruses |
| 12/27/1989 | CN1006198B Method of the virus-inactivating heat treatment of gamma-globulin and heat-treated aqueous solution containing the same |
| 12/26/1989 | US4889800 Synthetic polypeptides and receptor molecules derived therefrom and methods of use |
| 12/20/1989 | EP0347365A2 HIV-2 virus variants |
| 12/20/1989 | EP0347230A2 Miniclones |